scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.20549 |
P698 | PubMed publication ID | 15476213 |
P50 | author | Kaleb Michaud | Q60309895 |
P2093 | author name string | Theodore Pincus | |
Frederick Wolfe | |||
P433 | issue | 10 | |
P304 | page(s) | 3296-3305 | |
P577 | publication date | 2004-10-01 | |
P1433 | published in | Arthritis and Rheumatism | Q23929027 |
P1476 | title | Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire | |
P478 | volume | 50 |
Q37456247 | A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout |
Q36087437 | A comparison of the measurement properties of the Juvenile Arthritis Functional Assessment Scale with the childhood health assessment questionnaire in daily practice |
Q35893925 | A computer-adaptive disability instrument for lower extremity osteoarthritis research demonstrated promising breadth, precision, and reliability |
Q35986276 | A psychometric assessment of the St. George's respiratory questionnaire in patients with COPD using Rasch model analysis |
Q53604189 | Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach. |
Q84430492 | Assessment and treatment of psoriatic spondylitis |
Q40275209 | Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis |
Q33596873 | Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis |
Q33456382 | Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis |
Q63683454 | Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? |
Q34192955 | Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis |
Q33783212 | Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis |
Q36001279 | Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis |
Q47648732 | Detecting functional change in response to exercise in knee osteoarthritis: a comparison of two computerized adaptive tests |
Q37329497 | Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis. |
Q36832455 | Development of an Expanded Measure of Physical Functioning for Older Persons in Epidemiologic Research. |
Q90413147 | Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study |
Q35233200 | Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference |
Q33454543 | Dutch translation and cross-cultural adaptation of the PROMIS® physical function item bank and cognitive pre-test in Dutch arthritis patients |
Q34279148 | Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer |
Q64091747 | Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial |
Q36892258 | Employee health and presenteeism: a systematic review |
Q47104420 | Establishing the Validity and Reliability Evidence of Preceptor Assessment of Student Tool |
Q92681376 | Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus |
Q35638560 | Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept |
Q37377948 | Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs. |
Q48160536 | Experiences of gout-related disability from the patients' perspective: a mixed methods study |
Q35892991 | Foot and ankle characteristics associated with falls in adults with established rheumatoid arthritis: a cross-sectional study |
Q34929669 | Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug |
Q36732747 | Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis |
Q87883462 | Intramuscular Fat Accumulation and Associations With Body Composition, Strength, and Physical Functioning in Patients With Rheumatoid Arthritis |
Q37848117 | Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis |
Q56338557 | Long-term clinical outcomes of Zika-associated Guillain-Barré syndrome |
Q90146973 | Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study |
Q34916347 | MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage |
Q37953471 | Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature |
Q33234551 | Measuring disease activity for rheumatoid arthritis |
Q33459408 | Measuring everyday functional competence using the Rasch assessment of everyday activity limitations (REAL) item bank. |
Q39550704 | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness |
Q34462876 | Modern psychometrics applied in rheumatology--a systematic review |
Q46442996 | Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density |
Q38195568 | Patient involvement in outcome measures for psoriatic arthritis |
Q41670046 | Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation |
Q55655944 | Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS). |
Q52572093 | Predictors of activity limitation in people with gout: a prospective study |
Q45629572 | Psychometric evaluation of the WHOQOL-BREF in community-dwelling older people in Taiwan using Rasch analysis |
Q36204125 | QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries |
Q36780940 | Quantitative measures to assess patients with rheumatic diseases: 2006 update |
Q55241374 | Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study. |
Q35073601 | Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout |
Q36200687 | Reliability of the TekScan MatScan® system for the measurement of postural stability in older people with rheumatoid arthritis |
Q35449556 | Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria |
Q33637603 | Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice |
Q48513739 | Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment |
Q33456417 | The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency |
Q33725571 | The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors |
Q37544776 | The cost and impact of health conditions on presenteeism to employers: a review of the literature |
Q45033567 | The experience and impact of gout in Māori and Pacific people: a prospective observational study |
Q34505894 | Topical Ginger Treatment With a Compress or Patch for Osteoarthritis Symptoms |
Q57469543 | Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric |
Q34618811 | Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients |
Q33871735 | Use of accommodations for valued life activities: prevalence and effects on disability scores |
Q36302285 | Usefulness of patients-reported outcomes in rheumatoid arthritis focus group |
Q33455269 | Validation of a mobility item bank for older patients in primary care |
Q35953509 | Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritis |
Q58220872 | Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation |
Q37207061 | Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study |
Search more.